Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Ended earlyNCT00929162
What this trial is testing

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Patients With Advanced Ovarian Cancer Sensitive to Platinum-based Chemotherapy
AstraZeneca 120
Testing effectiveness (Phase 2)Study completedNCT00610714
What this trial is testing

AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian NeoplasmsOvarian Cancer
AstraZeneca 211

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation